J&J to divide drug group into three units

05/7/2006 | NYTimes.com

Johnson & Johnson plans to divide its pharmaceuticals group into three areas -- one for pain, infectious disease, cardiovascular and primary care, the central nervous system and metabolism; a second for cancer research, biotechnology and immunology; and a third for virology -- each providing research and development on specific health targets. Executives told employees the change would improve synergy between the company's research efforts and commercial opportunities.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ